ANATOMIC STAGE IV BREAST CANCER AJCC V8
Clinical trials for ANATOMIC STAGE IV BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new ANATOMIC STAGE IV BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for ANATOMIC STAGE IV BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation drug aims to slow bone tumors in advanced cancer
Disease control Not yet recruitingThis early-phase study tests a new drug (Sn-117m-DTPA) that delivers low-level radiation directly to bone tumors while being gentler on bone marrow. It is for people with prostate, breast, or lung cancer that has spread to the bones. The main goals are to find the safest dose and…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:26 UTC
-
New combo approach targets limited-spread breast cancer: surgery plus radiation may extend life
Disease control Not yet recruitingThis study looks at whether adding focused treatments like surgery and radiation to standard drug therapy can help people with HER2-positive stage IV breast cancer that has spread to only a few spots. About 562 participants will either get standard drugs alone or drugs plus local…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 26, 2026 04:24 UTC
-
New radiation therapy aims to shrink advanced breast tumors
Disease control Not yet recruitingThis early-phase study tests a drug called 177Lu-DOTATATE in 10 people with stage IV or recurrent breast cancer. The drug targets cancer cells that have a specific marker (SSTR2) and delivers radiation to kill them. The goal is to see if it can shrink tumors and reduce cancer ste…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
Heart drug may reboot immune attack on tough breast cancer
Disease control Not yet recruitingThis study tests whether adding a common heart medication (propranolol) to an immunotherapy drug (pembrolizumab) can help shrink tumors in people with advanced triple-negative breast cancer that has stopped responding to standard treatment. About 37 adults whose cancer has spread…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 03:54 UTC
-
Smart report aims to match breast cancer patients with best drugs
Knowledge-focused Not yet recruitingThis early-stage study tests whether a special report, created from a patient's tumor tissue, can help doctors choose the most effective treatments for advanced hormone receptor-positive breast cancer. The report looks at the cancer's biology to suggest which drugs might work and…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:11 UTC